# Chitosan-Nanoencapsulated Curcumin for the Treatment of Diabetic Foot Ulcers: A Review

**Authors:** Laura Andrea Gómez-de la Cruz, Juan David Rodríguez Macías, Carlos David Grande-Tovar

PMC · DOI: 10.3390/polym18040511 · 2026-02-19

## TL;DR

This paper reviews how chitosan-encapsulated curcumin can help treat diabetic foot ulcers by improving wound healing and reducing inflammation and infection.

## Contribution

The paper introduces a comprehensive review of chitosan–curcumin nanosystems for diabetic wound healing, highlighting their combined therapeutic mechanisms.

## Key findings

- Chitosan–curcumin systems show anti-inflammatory, antioxidant, and antimicrobial effects in diabetic wound healing.
- The system improves cell migration, fibroblast proliferation, collagen deposition, and re-epithelialization.
- Chitosan enhances curcumin delivery and contributes to healing through its antimicrobial and hemostatic properties.

## Abstract

Diabetic foot ulcers (DFUs) are wounds characterized by chronic inflammation and elevated oxidative stress that delay tissue regeneration and render them susceptible to infection, thereby complicating healing. Therefore, treating DFUs effectively is often challenging and requires a combined approach that integrates anti-inflammatory, antioxidant, and antibacterial effects. Curcumin, a widely studied natural compound, has shown promise in wound healing by modulating inflammation, oxidative stress, and infections. However, its bioavailability, absorption, and solubility issues limit its clinical applications. To overcome these limitations, curcumin has been incorporated into nanosystems, such as hydrogels, nanofibers, nanoparticles, vesicles, and micelles, thereby improving its delivery and enabling efficient local administration. Among these nanosystems, those formulated with chitosan are of particular interest due to chitosan’s intrinsic wound-healing properties. For that reason, this review comprehensively analyzes the literature on the therapeutic mechanisms of the chitosan–curcumin system for diabetic wound closure and compares them with those of free curcumin. The results show that this system exerts anti-inflammatory, antioxidant, and antimicrobial effects through specific mechanisms, including macrophage polarization, modulation of oxidative stress, and alteration of bacterial cell walls. In addition, significant improvements are observed in key healing processes, including cell migration, fibroblast proliferation, collagen deposition, and re-epithelialization. It should be noted that chitosan not only promotes curcumin release but also contributes to its therapeutic effect through its inherent antimicrobial and hemostatic properties, reinforcing its potential as a comprehensive strategy for the treatment of DFUs.

## Linked entities

- **Chemicals:** curcumin (PubChem CID 969516), chitosan (PubChem CID 129662530)

## Full-text entities

- **Genes:** NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 81687], PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, Tlr4 (toll-like receptor 4) [NCBI Gene 29260], Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Aqp3 (aquaporin 3 (Gill blood group)) [NCBI Gene 65133], IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CD86 (CD86 molecule) [NCBI Gene 942] {aka B7-2, B7.2, B70, BU63, CD28LG2, CD86 v6}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, Casp3 (caspase 3) [NCBI Gene 25402] {aka CPP32-beta, Lice, Yama}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, PON1 (paraoxonase 1) [NCBI Gene 5444] {aka ESA, MVCD5, PON}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 29527] {aka COX-2, Cox2, PGHS-2, PHS II, Pghs2}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, NPHS2 (NPHS2 stomatin family member, podocin) [NCBI Gene 7827] {aka PDCN, SRN1}, Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, Il4 (interleukin 4) [NCBI Gene 287287] {aka Il4e12}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], TGFA (transforming growth factor alpha) [NCBI Gene 7039] {aka TFGA}, CD80 (CD80 molecule) [NCBI Gene 941] {aka B7, B7-1, B7.1, BB1, CD28LG, CD28LG1}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, ARG1 (arginase 1) [NCBI Gene 383]
- **Diseases:** cytotoxic (MESH:D064420), dehydration (MESH:D003681), infected wounds (MESH:D014946), Ulcers (MESH:D014456), cardiovascular diseases (MESH:D002318), Infections (MESH:D007239), DFU (MESH:D017719), MRSA (MESH:D013203), skin defect (MESH:D012868), chronic (MESH:D002908), diabetic nephropathy (MESH:D003928), type I diabetes mellitus (MESH:D003922), Bacterial infections (MESH:D001424), Diabetes (MESH:D003920), mitochondrial dysfunction (MESH:D028361), Inflammatory (MESH:D007249), injury to (MESH:D014947), hyperglycemia (MESH:D006943), hypoxia (MESH:D000860), burn (MESH:D002056), osteoarthritis (MESH:D010003), metabolic disease (MESH:D008659)
- **Chemicals:** hydroxyapatite (MESH:D017886), PCL (MESH:C016240), Pluronic P123 (MESH:C464484), N-acetyl-D-glucosamine (MESH:D000117), MDA (MESH:D008315), celecoxib (MESH:D000068579), PVA (MESH:D011142), MTT (MESH:C070243), F127 (MESH:C078661), H2O2 (MESH:D006861), BioRender (-), superoxide (MESH:D013481), thiazolyl blue tetrazolium bromide (MESH:C022616), CUR (MESH:D003474), CuO (MESH:C030973), magnesium (MESH:D008274), glucose (MESH:D005947), ROS (MESH:D017382), oxide (MESH:D010087), Tween 80 (MESH:D011136), poly(lactide-co-glycolide) (MESH:D011098), PLGA (MESH:D000077182), cellulose (MESH:D002482), hydrogen (MESH:D006859), heparin (MESH:D006493), TBAR (MESH:D017392), lipid (MESH:D008055), poly (L-lactic acid) (MESH:C033616), bisdemethoxycurcumin (MESH:C034786), alpha-tocopherol (MESH:D024502), trimethoprim-sulfamethoxazole (MESH:D015662), lignin (MESH:D008031), TiO2 (MESH:C009495), GSH (MESH:D005978), chitin (MESH:D002686), polymer (MESH:D011108), carbon (MESH:D002244), GO (MESH:C000628730), polyol (MESH:C024617), MOFs (MESH:D000073396), CMP (MESH:D003568), polysaccharide (MESH:D011134), polyethylene glycol (MESH:D011092), prostaglandins (MESH:D011453), polypropylene carbonate (MESH:C039211), maltodextrin (MESH:C008315), CS (MESH:D048271), LCH (MESH:C047106), alginate (MESH:D000464), molecular oxygen (MESH:D010100), zinc (MESH:D015032), metal (MESH:D008670), Au (MESH:D006046), singlet oxygen (MESH:D026082), methicillin (MESH:D008712), hyaluronic acid (MESH:D006820), silver (MESH:D012834), demethoxycurcumin (MESH:C050229), carboxymethyl chitosan (MESH:C514968), arachidonic acid (MESH:D016718)
- **Species:** Homo sapiens (human, species) [taxon 9606], Proteus mirabilis (species) [taxon 584], Staphylococcus aureus (species) [taxon 1280], Rattus norvegicus (brown rat, species) [taxon 10116], Mycobacterium tuberculosis (species) [taxon 1773], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Curcuma aromatica (wild turmeric, species) [taxon 136209], Nannizzia gypsea (species) [taxon 63402], Salmonella enterica subsp. enterica serovar Paratyphi A (no rank) [taxon 54388], Stenotrophomonas maltophilia (species) [taxon 40324], Proteus vulgaris (species) [taxon 585], Staphylococcus haemolyticus (species) [taxon 1283], Fejervarya limnocharis (Boie's wart frog, species) [taxon 110108], Achromobacter xylosoxidans (species) [taxon 85698], Curcuma longa (turmeric, species) [taxon 136217], Acinetobacter lwoffii (species) [taxon 28090], Klebsiella pneumoniae (species) [taxon 573], Pseudomonas aeruginosa (species) [taxon 287], Mus musculus (house mouse, species) [taxon 10090], Bacillus subtilis (species) [taxon 1423], Escherichia coli (E. coli, species) [taxon 562], aureus [taxon 46170], Streptococcus pyogenes (species) [taxon 1314], Burkholderia cepacia (species) [taxon 292], Enterococcus faecalis (species) [taxon 1351]
- **Cell lines:** HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038), HFF-1 — Homo sapiens (Human), Finite cell line (CVCL_3285), HS68 — Homo sapiens (Human), Canavan disease, Finite cell line (CVCL_0839), L-929 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_AR58)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944176/full.md

---
Source: https://tomesphere.com/paper/PMC12944176